2021
DOI: 10.1007/s40264-021-01089-5
|View full text |Cite
|
Sign up to set email alerts
|

NSAIDs and COVID-19: A Systematic Review and Meta-analysis

Abstract: Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, fearing that they could increase the risk of infection or the severity of SARS-CoV-2. Methods Original studies providing information on exposure to NSAIDs and coronavirus disease 2019 (COVID-19) outcomes were retrieved and were included in a descriptive analysis and a meta-analysis with Cochrane Revu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
50
0
3

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(55 citation statements)
references
References 56 publications
1
50
0
3
Order By: Relevance
“…A study analyzing data from ISARIC Clinical Characterization Protocol UK cohort found NSAIDS use not disposing to any poor COVID-19 outcome (38). A 2021 systematic review and meta-analysis reiterated similar findings and revealed no negative association between use of NSAIDS, including Ibuprofen, with SARS-CoV-2 infection or its outcomes (39). Ibuprofen has been known to have a better analgesic response in men while higher threshold and greater tolerance for electrically induced pain, responded significantly to ibuprofen in contrast to women (40).…”
Section: Discussionmentioning
confidence: 93%
“…A study analyzing data from ISARIC Clinical Characterization Protocol UK cohort found NSAIDS use not disposing to any poor COVID-19 outcome (38). A 2021 systematic review and meta-analysis reiterated similar findings and revealed no negative association between use of NSAIDS, including Ibuprofen, with SARS-CoV-2 infection or its outcomes (39). Ibuprofen has been known to have a better analgesic response in men while higher threshold and greater tolerance for electrically induced pain, responded significantly to ibuprofen in contrast to women (40).…”
Section: Discussionmentioning
confidence: 93%
“…In a prospective cohort study of over 70,000 patients, Drake et al demonstrated that exposure to ibuprofen or other NSAIDs within 2 weeks of admission for COVID-19 had no effect on the requirement for oxygen, the need for invasive ventilation, acute kidney injury, admission to intensive care or mortality [31]. A recently published meta-analysis of 19 original studies, providing information on exposure to NSAIDs and COVID-19 outcomes, identified that there was no excess risk of acquiring COVID-19 in patients exposed to NSAIDs [32]. Furthermore, for patients infected with SARS-CoV-2, NSAID exposure did not increase the risk of hospital admissions, severe outcomes or death [32].…”
Section: Discussionmentioning
confidence: 99%
“…A recently published meta-analysis of 19 original studies, providing information on exposure to NSAIDs and COVID-19 outcomes, identified that there was no excess risk of acquiring COVID-19 in patients exposed to NSAIDs [32]. Furthermore, for patients infected with SARS-CoV-2, NSAID exposure did not increase the risk of hospital admissions, severe outcomes or death [32]. The review concluded that "the theoretical risks of NSAIDs or ibuprofen in SARS-CoV-2 infection are not confirmed by observational data" [32].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…PPCPs can be bioaccumulative, carcinogenic, and toxic to humans, wildlife, and flora, justifying the growing concern about their toxicity and disposal [ 12 , 13 ]. It should also be emphasized that the COVID-19 pandemic has boosted the consumption of pharmaceuticals, which justifies investigating the remediation of these pollutants in water bodies [ 14 ]. The academic community has become very concerned about the increasing concentration of these products in urban sewage and the subsequent contamination of the environment [ 15 ].…”
Section: Introductionmentioning
confidence: 99%